Enzon Pharmaceuticals, Inc. (ENZND)

4.03 -1.85 (-31.46%) USD  |  OTCM  |  Mar 25, 16:00
More

Enzon Pharmaceuticals Free Cash Flow Per Share (Quarterly)

Free Cash Flow Per Share (Quarterly) Chart

View Free Cash Flow Per Share (Quarterly) for ENZND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Per Share (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Free Cash Flow Per Share (Quarterly) Range, Past 5 Years

View Free Cash Flow Per Share (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Per Share (Quarterly) Benchmarks

View Free Cash Flow Per Share (Quarterly) Benchmarks
Start Trial
Agenus, Inc. Upgrade
Curis, Inc. Upgrade
Windtree Therapeutics, Inc. Upgrade
Halozyme Therapeutics, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade

Free Cash Flow Per Share (Quarterly) Related Metrics

Cash from Operations (Quarterly) Upgrade
Free Cash Flow Upgrade
Free Cash Flow to Equity (Quarterly) Upgrade
Free Cash Flow to Firm (Quarterly) Upgrade
Free Cash Flow Yield Upgrade